CSI Market
Sign In | Register

Conmed (CNMD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CNMD quarterly Cash Flow →
The table below presents a historical view of Conmed's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income47.06
Depreciation & amortization17.14
Amortization of Other Assets62.78
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability22.95
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-6.73
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation28.32
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Write Off Of Deferred Debt Issuance Cost0.36
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Gain On Sale Of A Product Line-
Income taxes2.97
Gain (Loss) on Sale of Properties0.00
Accounts Receivable12.55
Increase (Decrease) in Accounts Payable-9.75
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-6.97
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities170.69
Investing Activities
Capital Expenditures-19.81
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments Related To Business Acquisitions And Distribution Agreement-
Payments Related To Distribution Agreement-
Paymentsto Acquire Businesses Net of Cash Acquired and Asset Acquisitions-
Paymentsrelatedtobusinessacquisitionsandassetacquisitions-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-1.15
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-20.96
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-2.90
Long-term debt - borrowings25.23
Long-term debt - repayments-99.82
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.17
Payments For Contingent Payments-
Payments for Contingent Consideration Relatedto Business Acquisition-
Payments for Contingent Consideration Relatedto Asset Acquisition-
Payments Of Convertible Hedges-
Purchases of Convertible Notes Hedges-
Payments For Contingent Consideration-33.76
Payments For Convertible Notes Hedges-
Payments Of Convertible Notes Hedges-
Proceeds From Settlement Of Convertible Notes Hedge Transactions-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-24.75
Net Cash Flow from Financing Activities-135.82
Effect of exchange rate on cash flow2.45
Discontinued operations0.00
Free Cash Flow150.88
Total Cash Flow16.36
4 historic quarters locked

Sign in to unlock the full Conmed cash flow history.

Sign In Create Free Account

About Conmed Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: cnmd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000816956-26-000009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License